SYNPHASIC-28 TABLETS DIN 00695734
Health Canada record
| Active ingredient(s) | NORETHINDRONE .5 MG; ETHINYL ESTRADIOL .035 MG; NORETHINDRONE 1 MG; ETHINYL ESTRADIOL .035 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G03AB04 NORETHISTERONE AND ESTROGEN |
| Original market date | 31-Dec-1986 |
| Current status date | 30-Sep-1996 |
| Source | Health Canada DPD |
Establishment licence of the holder
Syntex S.A. — licence , not currently licensed, last inspection rating I (2025-11-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NORETHINDRONE .5 MG
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00373265 | BREVICON 0.5/35 21 TAB | SYNTEX INC. | Tablet | NORETHINDRONE .5 MG; ETHINYL ESTRADIOL .035 MG | Cancelled Post Market |
| 00373273 | BREVICON 0.5/35 28 TAB | SYNTEX INC. | Tablet | NORETHINDRONE .5 MG; ETHINYL ESTRADIOL .035 MG | Cancelled Post Market |
| 00317047 | ORTHO 0.5/35 TABLETS (21 DAY) | JANSSEN INC | Tablet | NORETHINDRONE .5 MG; ETHINYL ESTRADIOL .035 MG | Cancelled Post Market |
| 00538590 | ORTHO 10/11 TABLETS (21 DAY) | JANSSEN INC | Tablet | NORETHINDRONE .5 MG; ETHINYL ESTRADIOL .035 MG; NORETHINDRONE 1 MG; ETHINYL ESTRADIOL .035 MG | Cancelled Post Market |
| 00538582 | ORTHO 10/11 TABLETS (28 DAY) | JANSSEN INC | Tablet | NORETHINDRONE .5 MG; ETHINYL ESTRADIOL .035 MG; NORETHINDRONE 1 MG; ETHINYL ESTRADIOL .035 MG | Cancelled Post Market |
| 00620947 | SYNPHASIC 21 TABLETS | SYNTEX INC. | Tablet | NORETHINDRONE .5 MG; ETHINYL ESTRADIOL .035 MG; NORETHINDRONE 1 MG; ETHINYL ESTRADIOL .035 MG | Cancelled Post Market |